ACTIVE_NOT_RECRUITING

Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Insomnia is common in people who are in treatment for alcohol use disorder. It can impact both sleep quality and daytime functioning, as well as make it harder to treat the underlying alcohol use disorder. This study is looking at two types of therapy to help manage insomnia specifically for people also in treatment for alcohol use disorder.

Official Title

Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes

Quick Facts

Study Start:2020-11-15
Study Completion:2026-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04457674

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Meet probable Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for Alcohol Use Disorder with ≤12 weeks of abstinence
  2. * Planned enrollment into an abstinence-based treatment program
  3. * Meet probable DSM-5 criteria for chronic insomnia, confirmed with sleep diary
  4. * Ability to travel to Ann Arbor for sleep laboratory assessments
  5. * Access to a video chat-capable device and reliable Wi-Fi network
  1. * Diagnosis of, or high suspicion for, sleep disorders other than insomnia
  2. * Meet probable DSM-5 criteria for bipolar disorder, psychotic disorder, or post-traumatic stress disorder (PTSD)
  3. * Terminal or progressive physical illness (e.g., cancer), neurological degenerative disease (e.g., dementia), or presence of an unstable medical condition that is the specific cause of insomnia
  4. * Self-reported pregnancy or intention to become pregnant during the study

Contacts and Locations

Principal Investigator

J Todd Arnedt, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

The University of Michigan
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • J Todd Arnedt, Ph.D., PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-11-15
Study Completion Date2026-02-28

Study Record Updates

Study Start Date2020-11-15
Study Completion Date2026-02-28

Terms related to this study

Keywords Provided by Researchers

  • Cognitive Behavioral Therapy
  • Sleep Hygiene

Additional Relevant MeSH Terms

  • Insomnia
  • Alcohol Use Disorder